These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease. Barker RA; Ratcliffe E; McLaughlin M; Richards A; Dunnett SB J Neurosci; 2000 May; 20(9):3415-24. PubMed ID: 10777804 [TBL] [Abstract][Full Text] [Related]
10. Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity. Begum NA; Murakami Y; Mikata S; Matsumoto M; Hatanaka M; Nagasawa S; Kinoshita T; Seya T Immunology; 2000 May; 100(1):131-9. PubMed ID: 10809968 [TBL] [Abstract][Full Text] [Related]
11. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection. Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290 [No Abstract] [Full Text] [Related]
12. Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation. Miyagawa S; Matsunami K; Yoshitatsu M; Mikata S; Matsuda H; Shirakura R J Card Surg; 2001; 16(6):429-38. PubMed ID: 11925023 [No Abstract] [Full Text] [Related]
13. Complement activation, its consequences, and blockade by gene transfer. Carrington CA; Richards AC; van den Bogaerde J; Tucker AW; White DJ World J Surg; 1997; 21(9):907-12. PubMed ID: 9361503 [TBL] [Abstract][Full Text] [Related]
14. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry. Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716 [TBL] [Abstract][Full Text] [Related]
15. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives]. Malassagne B; Calmus Y; Houssin D; Weill B Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402 [TBL] [Abstract][Full Text] [Related]
16. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts. Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270 [TBL] [Abstract][Full Text] [Related]
17. [Significance of the complement system for xenotransplantation: strategies for therapeutic intervention]. Kirschfink M; Haferkamp A; Pomer S; Chrupcala M; Wosnik A; Heckl-Ostreicher B Zentralbl Chir; 1998; 123(7):793-7. PubMed ID: 9746977 [TBL] [Abstract][Full Text] [Related]
18. Prevention of hyperacute xenograft rejection in orthotopic xenotransplantation of pig hearts into baboons using immunoadsorption of antibodies and complement factors. Brenner P; Reichenspurner H; Schmoeckel M; Wimmer C; Rucker A; Eder V; Meiser B; Hinz M; Felbinger T; Hammer C; Reichart B Transpl Int; 2000; 13 Suppl 1():S508-17. PubMed ID: 11112063 [TBL] [Abstract][Full Text] [Related]
19. Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein. Mikata S; Miyagawa S; Iwata K; Nagasawa S; Hatanaka M; Matsumoto M; Kamiike W; Matsuda H; Shirakura R; Seya T Transplantation; 1998 Feb; 65(3):363-8. PubMed ID: 9484752 [TBL] [Abstract][Full Text] [Related]